Cargando…

A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Purpose This study was conducted to determine factors that influence palliative care (PC) consultation in patients receiving cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). Patient and methods We queried our Electronic Medical Record EPIC for a list of patients wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez, Robin R, Babar, Laila, Lo, Herman, Ashraf, Obaid, Monga, Dulabh, Finley, Gene, Doverspike, Lisa, Blackledge, Amber, Sethi, Ashish, Raj, Moses S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870133/
https://www.ncbi.nlm.nih.gov/pubmed/33575150
http://dx.doi.org/10.7759/cureus.12589
_version_ 1783648753320722432
author Rodriguez, Robin R
Babar, Laila
Lo, Herman
Ashraf, Obaid
Monga, Dulabh
Finley, Gene
Doverspike, Lisa
Blackledge, Amber
Sethi, Ashish
Raj, Moses S
author_facet Rodriguez, Robin R
Babar, Laila
Lo, Herman
Ashraf, Obaid
Monga, Dulabh
Finley, Gene
Doverspike, Lisa
Blackledge, Amber
Sethi, Ashish
Raj, Moses S
author_sort Rodriguez, Robin R
collection PubMed
description Purpose This study was conducted to determine factors that influence palliative care (PC) consultation in patients receiving cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). Patient and methods We queried our Electronic Medical Record EPIC for a list of patients who underwent cytoreductive surgery with HIPEC or hyperthermic intrathoracic chemotherapy (HITEC) in the hospital from April 2016-April 2019. Data was manually extracted and patients who did not meet our criteria were excluded. Patients were divided on the basis of palliative care consults and differences between the groups were analyzed. Odds ratios (OR) with p-value of 0.05 and confidence interval of (CI) 95% were calculated. Results We identified 55 patients of whom 34 met our inclusion criteria: 11 males and 23 females with an average age of 56 years at the time of diagnosis. Eight patients (23%) had PC, with six having commercial insurance, seven married, and six with more than one comorbid medical issue. Comorbidities >1 (OR: 0.12; CI: 0.02-0.76; p: 0.02) and age >40 (OR: 0.015; CI: 0.0007-0.3029; P: 0.006) were associated with a higher likelihood of PC. Gender, insurance type, and marital status did not have a significant association with PC. Mean age between PC consulted patients versus non-PC consulted patients was 58.5 vs. 55.9 and median age between the two groups was 60.5 vs. 60 which also showed a trend towards higher rates of PC in the older population. Conclusion Approximately one quarter of patients who underwent CRS with HIPEC had a concurrent PC consult. Though this is better than the national average of 11-16%, it continues to be a very small number. Efforts must be made to engage PC early in the course of treatment and recognize it as an integral part of cancer care. PC is not only an end-of-life service, in fact, studies have shown that early consultations lead to higher patient satisfaction, improved quality of life, and better communication.
format Online
Article
Text
id pubmed-7870133
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-78701332021-02-10 A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Rodriguez, Robin R Babar, Laila Lo, Herman Ashraf, Obaid Monga, Dulabh Finley, Gene Doverspike, Lisa Blackledge, Amber Sethi, Ashish Raj, Moses S Cureus Medical Education Purpose This study was conducted to determine factors that influence palliative care (PC) consultation in patients receiving cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). Patient and methods We queried our Electronic Medical Record EPIC for a list of patients who underwent cytoreductive surgery with HIPEC or hyperthermic intrathoracic chemotherapy (HITEC) in the hospital from April 2016-April 2019. Data was manually extracted and patients who did not meet our criteria were excluded. Patients were divided on the basis of palliative care consults and differences between the groups were analyzed. Odds ratios (OR) with p-value of 0.05 and confidence interval of (CI) 95% were calculated. Results We identified 55 patients of whom 34 met our inclusion criteria: 11 males and 23 females with an average age of 56 years at the time of diagnosis. Eight patients (23%) had PC, with six having commercial insurance, seven married, and six with more than one comorbid medical issue. Comorbidities >1 (OR: 0.12; CI: 0.02-0.76; p: 0.02) and age >40 (OR: 0.015; CI: 0.0007-0.3029; P: 0.006) were associated with a higher likelihood of PC. Gender, insurance type, and marital status did not have a significant association with PC. Mean age between PC consulted patients versus non-PC consulted patients was 58.5 vs. 55.9 and median age between the two groups was 60.5 vs. 60 which also showed a trend towards higher rates of PC in the older population. Conclusion Approximately one quarter of patients who underwent CRS with HIPEC had a concurrent PC consult. Though this is better than the national average of 11-16%, it continues to be a very small number. Efforts must be made to engage PC early in the course of treatment and recognize it as an integral part of cancer care. PC is not only an end-of-life service, in fact, studies have shown that early consultations lead to higher patient satisfaction, improved quality of life, and better communication. Cureus 2021-01-09 /pmc/articles/PMC7870133/ /pubmed/33575150 http://dx.doi.org/10.7759/cureus.12589 Text en Copyright © 2021, Rodriguez et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Medical Education
Rodriguez, Robin R
Babar, Laila
Lo, Herman
Ashraf, Obaid
Monga, Dulabh
Finley, Gene
Doverspike, Lisa
Blackledge, Amber
Sethi, Ashish
Raj, Moses S
A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
title A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
title_full A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
title_fullStr A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
title_full_unstemmed A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
title_short A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
title_sort retrospective analysis of factors affecting palliative care consults in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
topic Medical Education
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870133/
https://www.ncbi.nlm.nih.gov/pubmed/33575150
http://dx.doi.org/10.7759/cureus.12589
work_keys_str_mv AT rodriguezrobinr aretrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT babarlaila aretrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT loherman aretrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT ashrafobaid aretrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT mongadulabh aretrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT finleygene aretrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT doverspikelisa aretrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT blackledgeamber aretrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT sethiashish aretrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT rajmosess aretrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT rodriguezrobinr retrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT babarlaila retrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT loherman retrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT ashrafobaid retrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT mongadulabh retrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT finleygene retrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT doverspikelisa retrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT blackledgeamber retrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT sethiashish retrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy
AT rajmosess retrospectiveanalysisoffactorsaffectingpalliativecareconsultsinpatientsundergoingcytoreductivesurgeryandhyperthermicintraperitonealchemotherapy